In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

We'll also see how well it generates new data, and finally we'll go over the key limitations of the copilot function. At the very end, I'll show you an alternative function to the copilot formula in ...